These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1789788)

  • 1. Effect of radical treatment on erythrocyte lipid peroxidation in Plasmodium vivax-infected malaria patients.
    Mathews ST; Selvam R
    Biochem Int; 1991 Sep; 25(2):211-20. PubMed ID: 1789788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The haematology of Plasmodium vivax before and after chloroquine and primaquine treatment in north Madras area.
    Kumaresan PR; Selvam R
    Indian J Malariol; 1991 Jun; 28(2):115-20. PubMed ID: 1810747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of therapeutic efficacy of chloroquine for vivax malaria in Thailand.
    Vijaykadga S; Rojanawatsirivej C; Congpoung K; Wilairatana P; Satimai W; Uaekowitchai C; Pumborplub B; Sittimongkol S; Pinyorattanachote A; Prigchoo P
    Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):566-9. PubMed ID: 15689067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical alterations in Plasmodium vivax-infected malarial patients before and after radical treatment.
    Selvam R; Mathews ST
    Indian J Malariol; 1992 Jun; 29(2):103-11. PubMed ID: 1459303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poor response to primaquine in two cases of Plasmodium vivax malaria from Guatemala.
    Gascon J; Gomez Arce JE; Menendez C; Valls ME; Corachán M
    Trop Geogr Med; 1994; 46(1):32-3. PubMed ID: 8165734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of superoxide dismutase and catalase and the level of lipid peroxidation products reactive with TBA in patients with psoriasis.
    Drewa G; Krzyzyńska-Malinowska E; Woźniak A; Protas-Drozd F; Mila-Kierzenkowska C; Rozwodowska M; Kowaliszyn B; Czajkowski R
    Med Sci Monit; 2002 Aug; 8(8):BR338-43. PubMed ID: 12165738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chloroquine sensitivity of Plasmodium vivax in Thailand.
    Looareesuwan S; Wilairatana P; Krudsood S; Treeprasertsuk S; Singhasivanon P; Bussaratid V; Chokjindachai W; Viriyavejakul P; Chalermrut K; Walsh D S; White J
    Ann Trop Med Parasitol; 1999 Apr; 93(3):225-30. PubMed ID: 10562823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased glutathione-S-transferase activity: diagnostic and protective role in vivax malaria.
    Sohail M; Kaul A; Raziuddin M; Adak T
    Clin Biochem; 2007 Mar; 40(5-6):377-82. PubMed ID: 17307156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind, randomized study of azithromycin compared to chloroquine for the treatment of Plasmodium vivax malaria in India.
    Dunne MW; Singh N; Shukla M; Valecha N; Bhattacharyya PC; Patel K; Mohapatra MK; Lakhani J; Devi CU; Adak T; Dev V; Yadav RS; Lele C; Patki K
    Am J Trop Med Hyg; 2005 Dec; 73(6):1108-11. PubMed ID: 16354821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic failure wtih chloroquine and primaquine in malaria by Plasmodium vivax].
    Ocampo A; García-Bujalance S; Ladrón de Guevara C
    Enferm Infecc Microbiol Clin; 1998 Dec; 16(10):490-1. PubMed ID: 9919001
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of three chloroquine-primaquine regimens for treatment of Plasmodium vivax malaria in Colombia.
    Alvarez G; Piñeros JG; Tobón A; Ríos A; Maestre A; Blair S; Carmona-Fonseca J
    Am J Trop Med Hyg; 2006 Oct; 75(4):605-9. PubMed ID: 17038680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress and antioxidant defence mechanism in Plasmodium vivax malaria before and after chloroquine treatment.
    Sarin K; Kumar A; Prakash A; Sharma A
    Indian J Malariol; 1993 Sep; 30(3):127-33. PubMed ID: 8131881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neglect of Plasmodium vivax malaria.
    Baird JK
    Trends Parasitol; 2007 Nov; 23(11):533-9. PubMed ID: 17933585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic efficacy of artesunate in Plasmodium vivax malaria in Thailand.
    Hamedi Y; Safa O; Zare S; Tan-ariya P; Kojima S; Looareesuwan S
    Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):570-4. PubMed ID: 15689068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized trial of 3-dose regimens of tafenoquine (WR238605) versus low-dose primaquine for preventing Plasmodium vivax malaria relapse.
    Walsh DS; Wilairatana P; Tang DB; Heppner DG; Brewer TG; Krudsood S; Silachamroon U; Phumratanaprapin W; Siriyanonda D; Looareesuwan S
    Clin Infect Dis; 2004 Oct; 39(8):1095-103. PubMed ID: 15486831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine deaminase enzyme activity is increased and negatively correlates with catalase, superoxide dismutase and glutathione peroxidase in patients with Behçet's disease: original contributions/clinical and laboratory investigations.
    Erkiliç K; Evereklioglu C; Cekmen M; Ozkiris A; Duygulu F; Dogan H
    Mediators Inflamm; 2003 Apr; 12(2):107-16. PubMed ID: 12775361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on Plasmodium vivax relapse pattern in Kheda district, Gujarat.
    Srivastava HC; Sharma SK; Bhatt RM; Sharma VP
    Indian J Malariol; 1996 Dec; 33(4):173-9. PubMed ID: 9125831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of 5 day radical treatment of primaquine in Plasmodium vivax cases at the BHEL industrial complex, Hardwar (U.P.).
    Sinha S; Dua VK; Sharma VP
    Indian J Malariol; 1989 Jun; 26(2):83-6. PubMed ID: 2676618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vivax malaria: preliminary observations following a shorter course of treatment with artesunate plus primaquine.
    Dao NV; Cuong BT; Ngoa ND; Thuy le TT; The ND; Duy DN; Dai B; Thanh NX; Chavchich M; Rieckmann KH; Edstein MD
    Trans R Soc Trop Med Hyg; 2007 Jun; 101(6):534-9. PubMed ID: 17368694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Status of hepatic oxidative stress and antioxidant defense systems during chloroquine treatment of Plasmodium yoelii nigeriensis infected mice.
    Siddiqi NJ; Alhomida AS
    In Vivo; 1999; 13(6):547-50. PubMed ID: 10757052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.